[O1] Oral Session 1　Gastrointestinal Cancer 1（Upper GI Tract）
【E】

[O1-6] REVIVE study: An Observational Study in Chemotherapy (CTx) after Nivolumab (NIVO) for Advanced Gastric Cancer (AGC)

^○Yasuhiro Sakamoto¹, Yukiya Narita², Toshihiro Misumi³, Hiroshi Matsuoka⁴, Hiroaki Tanioka⁵, Takeshi Kawakami⁶, Tomohiro Matsushima⁷, Hiroto Miwa⁸, Hirokazu Shoji⁹, Atsushi Ishiguro¹⁰, Sachio Fushida¹¹, Kou Miura¹², Takanobu Yamada¹³, Katsunori Shinozaki¹⁴, Takuro Mizukami¹⁵, Tomohiro Nishina¹⁶, Toshikazu Moriwaki¹⁷, Seiichiro Mitani¹⁸, Michio Nakamura¹⁹, Kei Muro² (1.Department of Medical Oncology, Osaki Citizen Hospital, 2.Department of Clinical Oncology, Aichi Cancer Center Hospital, 3.Department of Biostatistics, Yokohama City University School of Medicine, 4.Department of Gastrointestinal Surgery School of Medicine, Fujita Health University Hospital, 5.Department of Clinical Oncology, Kawasaki Medical School, 6.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 7.Department of Gastroenterology, Saitama Cancer Center, 8.Division of Gastroenterology and Hepatology, Hyogo College of Medicine, 9.Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 10.Department of Medical Oncology, Teine Keijinkai Hospital, 11.Department of Gastroenterological Surgery, Kanazawa University Graduate School of Medical Sciences, 12.Department of Internal Medicine, Himeji Red Cross Hospital, 13.Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 14.Division of Clinical Oncology, Hiroshima Prefectural Hospital, 15.Department of Clinical Oncology, St. Marianna University School of Medicine, 16.Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 17.Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, 18.Department of Medical Oncology, Faculty of Medicine, Kindai University, 19.Department of Gastroenterology, Sapporo City General Hospital)